postmenopausal osteoporosis
Conditions
Interventions
Test group:Calcium D + Acupuncture(BL23\ST36\KI3\GB39\BL11\GB34)
Control group:Calcium D + sham acupuncture
Sponsors
Wangjing Hospital of China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1)Meets diagnostic criteria for postmenopausal osteoporosis (2)Patients with postmenopausal osteoporosis between the ages of 45 (inclusive) and 70 (exclusive) (3)Baseline VAS = 4 points and VAS < 7 points (4)Voluntary participation in this clinical study, signed informed consent form
Exclusion criteria
Exclusion criteria: (1)Secondary osteoporosis or history of osteoporotic fracture within the last 1 year (2)Combined with rheumatoid arthritis, osteoarthritis, diabetes, gastrointestinal diseases, etc. (3)Severe cardiac, hepatic, renal and other organ insufficiencies, hematologic and autoimmune diseases, acute and chronic infections, malignant tumors, or serious mental illnesses (4)History of thyroid, pituitary, hypothalamus and other endocrine disorders (5)Use of zoledronate within the last 1 year, use of disulfiramab within the last 6 months, oral bisphosphonates Salt, anti-osteoporosis herbal preparations such as bone care capsule, Jin Tian Ge capsule, etc. discontinued for less than 3 months (6)Year-round use of hormones such as glucocorticoids, sex hormones, active vitamin D, fluoride, anti-seizure epileptic drugs, etc. (7)Those unable to cooperate in completing this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Bone metabolism markers;Quality of life;Security indicators;TCM Syndrome Score; | — |
Countries
China
Contacts
Public ContactXu Wei
Outcome results
None listed